161 related articles for article (PubMed ID: 18987435)
1. Low, but physiological, concentration of GLP-1 stimulates insulin secretion independent of the cAMP-dependent protein kinase pathway.
Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
J Pharmacol Sci; 2008 Nov; 108(3):274-9. PubMed ID: 18987435
[TBL] [Abstract][Full Text] [Related]
2. A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion.
Shigeto M; Cha CY; Rorsman P; Kaku K
J Mol Med (Berl); 2017 Apr; 95(4):361-368. PubMed ID: 28097390
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
[TBL] [Abstract][Full Text] [Related]
6. TGR5 Activation Promotes Stimulus-Secretion Coupling of Pancreatic β-Cells via a PKA-Dependent Pathway.
Maczewsky J; Kaiser J; Gresch A; Gerst F; Düfer M; Krippeit-Drews P; Drews G
Diabetes; 2019 Feb; 68(2):324-336. PubMed ID: 30409782
[TBL] [Abstract][Full Text] [Related]
7. Triphenyltin impairs a protein kinase A (PKA)-dependent increase of cytosolic Na+ and Ca2+ and PKA-independent increase of cytosolic Ca2+ associated with insulin secretion in hamster pancreatic beta-cells.
Miura Y; Matsui H
Toxicol Appl Pharmacol; 2006 Nov; 216(3):363-72. PubMed ID: 16837018
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.
Bode HP; Moormann B; Dabew R; Göke B
Endocrinology; 1999 Sep; 140(9):3919-27. PubMed ID: 10465260
[TBL] [Abstract][Full Text] [Related]
9. [Theoretical Investigations into the Quantitative Mechanisms Underlying the Regulation of [cAMP]i, Membrane Excitability and [Ca(2+)]i during GLP-1 Stimulation in Pancreatic β Cells].
Takeda Y
Yakugaku Zasshi; 2016; 136(3):467-71. PubMed ID: 26935088
[TBL] [Abstract][Full Text] [Related]
10. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1.
Jacobo SM; Guerra ML; Hockerman GH
J Pharmacol Exp Ther; 2009 Nov; 331(2):724-32. PubMed ID: 19710366
[TBL] [Abstract][Full Text] [Related]
11. Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells.
Shang J; Li J; Keller MP; Hohmeier HE; Wang Y; Feng Y; Zhou HH; Shen X; Rabaglia M; Soni M; Attie AD; Newgard CB; Thornberry NA; Howard AD; Zhou YP
Mol Endocrinol; 2015 Sep; 29(9):1243-53. PubMed ID: 26218441
[TBL] [Abstract][Full Text] [Related]
12. Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels.
Zhang Y; Ding Y; Zhong X; Guo Q; Wang H; Gao J; Bai T; Ren L; Guo Y; Jiao X; Liu Y
Mol Cell Endocrinol; 2016 Jul; 430():89-96. PubMed ID: 27126219
[TBL] [Abstract][Full Text] [Related]
13. Glucotoxicity inhibits cAMP-protein kinase A-potentiated glucose-stimulated insulin secretion in pancreatic β-cells.
Kong X; Yan D; Wu X; Guan Y; Ma X
J Diabetes; 2015 May; 7(3):378-85. PubMed ID: 24981285
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
Ma X; Guan Y; Hua X
J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
[TBL] [Abstract][Full Text] [Related]
15. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Gromada J; Ding WG; Barg S; Renström E; Rorsman P
Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
[TBL] [Abstract][Full Text] [Related]
16. Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
McClenaghan NH; Flatt PR; Ball AJ
J Endocrinol; 2006 Sep; 190(3):889-96. PubMed ID: 17003289
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion.
Li N; Li B; Brun T; Deffert-Delbouille C; Mahiout Z; Daali Y; Ma XJ; Krause KH; Maechler P
Diabetes; 2012 Nov; 61(11):2842-50. PubMed ID: 22933115
[TBL] [Abstract][Full Text] [Related]
18. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
20. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
Jimenez-Feltstrom J; Lundquist I; Salehi A
Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
